These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10488192)

  • 21. Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates.
    Taylor DE; Chau AS
    Antimicrob Agents Chemother; 1997 Mar; 41(3):665-71. PubMed ID: 9056011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
    Takiff HE; Salazar L; Guerrero C; Philipp W; Huang WM; Kreiswirth B; Cole ST; Jacobs WR; Telenti A
    Antimicrob Agents Chemother; 1994 Apr; 38(4):773-80. PubMed ID: 8031045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
    Mouneimné H; Robert J; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1999 Jan; 43(1):62-6. PubMed ID: 9869566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
    Luo N; Sahin O; Lin J; Michel LO; Zhang Q
    Antimicrob Agents Chemother; 2003 Jan; 47(1):390-4. PubMed ID: 12499221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
    Musso D; Drancourt M; Osscini S; Raoult D
    Antimicrob Agents Chemother; 1996 Apr; 40(4):870-3. PubMed ID: 8849242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.
    Gales AC; Gordon KA; Wilke WW; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):61-4. PubMed ID: 10744370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Multiplex-Mismatch Amplification Mutation-PCR Assay for Simultaneous Detection of Campylobacter jejuni and Mutation in gyrA Gene Related to Fluoroquinolone Resistance.
    Cui M; Wu C; Zhang P; Wu C
    Foodborne Pathog Dis; 2016 Nov; 13(11):642-645. PubMed ID: 27584716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-level quinolone resistance in clinical isolates of Campylobacter jejuni.
    Segreti J; Gootz TD; Goodman LJ; Parkhurst GW; Quinn JP; Martin BA; Trenholme GM
    J Infect Dis; 1992 Apr; 165(4):667-70. PubMed ID: 1313069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.
    Korten V; Huang WM; Murray BE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2091-4. PubMed ID: 7811024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
    Sonnevend Á; Kovács J; Pál T; Akawi N; Nagelkerke N; Schneider G
    Scand J Infect Dis; 2011 Dec; 43(11-12):905-11. PubMed ID: 21905953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment.
    Griggs DJ; Johnson MM; Frost JA; Humphrey T; Jørgensen F; Piddock LJ
    Antimicrob Agents Chemother; 2005 Feb; 49(2):699-707. PubMed ID: 15673754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori.
    Moore RA; Beckthold B; Wong S; Kureishi A; Bryan LE
    Antimicrob Agents Chemother; 1995 Jan; 39(1):107-11. PubMed ID: 7695290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates.
    Walker RA; Saunders N; Lawson AJ; Lindsay EA; Dassama M; Ward LR; Woodward MJ; Davies RH; Liebana E; Threlfall EJ
    J Clin Microbiol; 2001 Apr; 39(4):1443-8. PubMed ID: 11283069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of ciprofloxacin-resistant Campylobacter jejuni and analysis of the gyrA gene by the LightCycler mutation assay.
    Dionisi AM; Luzzi I; Carattoli A
    Mol Cell Probes; 2004 Aug; 18(4):255-61. PubMed ID: 15271386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR.
    Rahman M; Mauff G; Levy J; Couturier M; Pulverer G; Glasdorff N; Butzler JP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2488-91. PubMed ID: 7840594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Ge B; McDermott PF; White DG; Meng J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A; Diver JM; Beckthold B; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.